TOKYO -- U.S. drugmaker Moderna has scrapped plans to build a messenger RNA (mRNA) vaccine plant in Japan, citing sluggish vaccine demand and poor business performance.
Pharmaceuticals
Moderna cancels Japan mRNA plant plans amid weak demand
Falling global demand prompts US drugmaker to scale back ambitions
Moderna Japan had planned to build an mRNA drug plant at Shonan Health Innovation Park in Kanagawa prefecture. The company shelved the plan, citing weak demand for vaccines and a poor business environment.
Read Next
Latest on Pharmaceuticals
